It is a safe, legal component and the only addictive thing is its smell. It's a new line that is sweeping, try it and find out why!
What is its texture like?
It is very light and not greasy. It is absorbed very quickly and does not leave a greasy feeling.
You only need a few drops to notice the results.
How to apply it?
With just a few drops you will notice hydrated skin, free of flaking and itching. In addition, you will have a nourished, luminous and soft beard.
Only two or three drops are necessary on the fingertips and apply to the beard with gentle massages in upward movements.
What is CBD and why is it safe?
CBD is one of more than one hundred “phytocannabinoids” that can be found exclusively in cannabis and that give the plant a highly therapeutic profile.
Likewise, it is safe because the World Health Organization, the UN and other institutions have already officially recognized the benefits of CBD. It is not an addictive substance, nor does it cause anxiety, paranoia, hallucinations or anxiety. This is because this substance does not contain tetrahydrocannabinol (THC), the psychoactive ingredient found in marijuana that produces these effects.
Is CBD legal?
Yeah! In many countries around the world, such as the USA, the United Kingdom and Canada, it is legal and its most widespread and recommended use is by applying a few drops under the tongue. However, in Spain only its topical use is regulated.
Does it have side effects?
It has no side effects when used topically (except those allergic reactions that could cause like any other product).
What does the WHO say about cannabidiol (CBD)?
About cannabidiol preparations. At its 40th meeting, the Expert Committee on Drug Dependence reviewed a critical review of cannabidiol and recommended that preparations considered pure cannabidiol should not be included in the schedules of the international drug control treaties.
Although cannabidiol is present in cannabis and cannabis resin, it does not have psychoactive properties or the potential to generate addiction and dependence. It also does not cause significant harmful effects.
It has been shown that cannabidiol can effectively treat certain childhood-onset epileptic disorders that do not respond to other treatments. It was approved for this indication in the United States of America in 2018, and the EU is currently considering authorizing it.
Cannabidiol can be obtained through chemical synthesis or from the cannabis plant. The authorized medicine (Epidiolex) is a preparation of the cannabis plant.
The Committee noted that medicines that do not have psychoactive effects and are manufactured as preparations of the cannabis plant contain traces of delta-9-tetrahydrocannabinol (Δ9-THC; dronabinol). Epidiolex, which is the cannabidiol preparation authorized to treat childhood-onset epilepsy, contains a maximum of 0.15 percent Δ9 -THC by weight and does not cause effects indicative of its potential for misuse or dependence. In accordance with the recommendation that preparations considered pure cannabidiol not be subject to control, recognizing the concentration of traces of Δ9 -THC that such preparations may contain (such as the 0.15 percent present in Epidiolex), and taking into account Note that, for some Member States, it may be difficult to perform chemical analyzes that can accurately detect concentrations of 0.15 percent of Δ 9 -THC:
Recommendation 5.5: The Committee recommended adding a footnote to Schedule I of the 1961 Single Convention on Narcotic Drugs stating: “Preparations containing predominantly cannabidiol and not more than 0.2 percent delta -9-tetrahydrocannabinol are not subject to international control.
(Verbatim quote from the Report of the 41st Committee of Experts on Drug Dependence, section 5.5 titled cannabis and cannabis-related substances).